Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region
Open Access
- 1 April 1998
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 78 (4) , 345-348
- https://doi.org/10.1136/adc.78.4.345
Abstract
BACKGROUND Antenatal screening for cystic fibrosis has been endorsed by the US National Institutes of Health. Edinburgh is the only city in the UK with an established routine antenatal screening programme for cystic fibrosis. AIMS To report the change in numbers of infants diagnosed with cystic fibrosis born in Edinburgh after the introduction of antenatal screening for the disease. POPULATION Infants diagnosed as having cystic fibrosis (by sweat test or genotyping, or both) in the seven years before antenatal testing (1984–90) and the first five years of antenatal testing (1991–95). Children born in this region who had moved before diagnosis were identified from the UK cystic fibrosis survey database. RESULTS The incidence of cystic fibrosis decreased from an average of 4.6 to 1.6 children each year with antenatal screening. The reduction in the incidence (65%) was greater than that accounted for by prenatal diagnosis and termination (36%). Of the eight children born with cystic fibrosis during the period of antenatal screening, five had been subject to antenatal screening: three had only one mutation identified, one was missed due to a laboratory error, and one was identified as a one in four risk, but prenatal diagnosis was not performed. CONCLUSIONS Antenatal testing for cystic fibrosis has successfully reduced the incidence of cystic fibrosis in this region. Although the numbers are small, it is possible that the reduction in numbers may have been greater than might be expected from antenatal screening alone. Antenatal screening for cystic fibrosis has produced an effective reduction in the number of new cases The reduction in the number of new cases of cystic fibrosis was greater than that expected from terminations after prenatal diagnosis The reasons for the greater than expected decrease in the number of cases of cystic fibrosis may represent a change in reproductive behaviour by couples identified as carriers The effective detection rate of antenatal screening would be improved if acceptance levels for antenatal screening programmes were improvedKeywords
This publication has 20 references indexed in Scilit:
- Prenatal screening for cystic fibrosis: 5 years' experience reviewedThe Lancet, 1996
- Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre.Thorax, 1995
- Neonatal screening for cystic fibrosis.Thorax, 1995
- Delayed diagnosis of cystic fibrosis in children with a rare genotype (ΔF508/R117H)Journal of Paediatrics and Child Health, 1995
- Prenatal cystic fibrosis carrier screening: Factors in a woman's decision to decline testingPrenatal Diagnosis, 1993
- The changing epidemiology of cystic fibrosisThe Journal of Pediatrics, 1993
- Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.Archives of Disease in Childhood, 1991
- Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosisClinical Genetics, 1990
- Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screeningThe Journal of Pediatrics, 1989
- Effect of screening for cystic fibrosis on the influence of genetic counselingClinical Genetics, 1987